Strattera and Mestinon drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Strattera (atomoxetine hydrochloride) and Mestinon (pyridostigmine bromide). Common drug interactions include gastroenteritis viral among females and drug ineffective among males.

The phase IV clinical study analyzes what interactions people have when they take Strattera and Mestinon. It is created by eHealthMe based on reports of 16 people who take the same drugs from the FDA, and is updated regularly.

What is Strattera?

Strattera has active ingredients of atomoxetine hydrochloride. It is often used in attention deficit hyperactivity disorder. eHealthMe is studying from 29,323 Strattera users. Check the latest studies of Strattera.

What is Mestinon?

Mestinon has active ingredients of pyridostigmine bromide. It is often used in myasthenia gravis. eHealthMe is studying from 5,948 Mestinon users. Check the latest studies of Mestinon.

On Jul, 15, 2026

16 people who take Strattera and Mestinon together, and have interactions are studied.

Strattera and Mestinon drug interactions.

What are the common drug interactions of Strattera and Mestinon, by gender? *:

female:

Gastroenteritis viral (inflammation of stomach and intestine caused by virus infection)
Urinary tract infection
Kidney infection
Migraine (headache)
Muscular weakness (muscle weakness)
Nausea (feeling of having an urge to vomit)
Nephrolithiasis (calculi in the kidneys)
Headache (pain in head)
Herpes zoster
Pain

male:

Drug ineffective
Eyelid ptosis (falling of the upper or lower eyelid)
Somnolence (a state of near-sleep, a strong desire for sleep)
Asthenia (weakness)
Death
Lung infection

What are the common drug interactions of Strattera and Mestinon, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

Drug ineffective
Eyelid ptosis (falling of the upper or lower eyelid)
Somnolence (a state of near-sleep, a strong desire for sleep)

20-29:

Seizure (abnormal excessive or synchronous neuronal activity in the brain)
Somnolence (a state of near-sleep, a strong desire for sleep)
Vomiting
Overdose

30-39:

Asthenia (weakness)
Lung infection
Migraine (headache)
Muscular weakness (muscle weakness)
Nail infection
Nausea (feeling of having an urge to vomit)
Nephrolithiasis (calculi in the kidneys)
Somnolence (a state of near-sleep, a strong desire for sleep)
Urinary tract infection
Vomiting

40-49:

n/a

50-59:

n/a

60+:

Death

What are the existing conditions these people have? *

Immunodeficiency Common Variable: 8 people, 50.00%
Humoral Immune Defect (impairment of humoral immunity): 8 people, 50.00%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 2 people, 12.50%
Insomnia (sleeplessness): 2 people, 12.50%
Drowsiness: 2 people, 12.50%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 2 people, 12.50%
Orthostatic Hypotension (a medical condition consisting of a sudden decrease in blood pressure when a person stands up): 1 person, 6.25%
Metastases To Bone (cancer spreads to bone): 1 person, 6.25%
Hypogammaglobulinaemia (an abnormally low concentration of gamma globulin in the blood and increased risk of infection): 1 person, 6.25%
Gastrointestinal Carcinoma (cancer of stomach or intestine): 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Strattera and Mestinon?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously